Establishment and characterization of a novel cancer cell line (SMOV-1), derived from the ascitic fluid of a woman with ovarian cancer who had never responded to chemotherapeutic drugs
- 43 Downloads
A novel cell line, designated SMOV-1, was established from the ascitic fluid of a woman with ovarian cancer. This report describes the process of establishment and characterization of this cell line.
The case involved a woman who had undergone a surgical intervention, due to a serous papillary adenocarcinoma of the ovary. She received the combination chemotherapy of PAC (cisplatin +doxorubicin+cyclophosphamide) 6 times after the surgery. However, as a result of malignant pleural effusion during chemotherapy, she died 7 months after surgery. Before surgery, ascitic fluid was removed from the patient for cell culture, after obtaining her consent. The cells were successfully subcultured, and designated SMOV-1.
The cell line gave a pavement-stone pattern, without contact inhibition. SMOV-1 could also be transplanted into nude mice, and the tissue showed reconstruction of the original tumor. The chromosome number of the SMOV-1 cells was 57, and the DNA index was 2.28. The population-doubling time of the SMOV-1 cells was 61.4 hours. Cultured SMOV-1 cells were still capable of producing the tumor-associated antigens CA 125, CA 19-9, and sTn (sialosyl-Tn).
We propose that this novel cell line is of possible use for the investigation of drug resistance in ovarian cancer.
Key wordsovarian cancer in vitro tumor marker drug resistance
Unable to display preview. Download preview PDF.
- 2.Robert CK, Ross SB. Gynecologic oncology. 2nd ed. New York: McGraw-Hill; 1993:250–255.Google Scholar
- 3.Disaia PJ, Creasman WT. Clinical Gynecologic Oncology. 4th ed. St. Louis: Mosby Year Book: 1993:387–391.Google Scholar
- 6.Miterman F (ed). ISCN 1991: Guidelines for Cancer Cytogenetics. New York: Karger; 1992:1–48.Google Scholar
- 7.Shapiro HM. Practical Flow Cytometry. 2nd ed. New York: Alan R Liss; 1988:115–140.Google Scholar